Crossmark

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study

Crossref DOI link: https://doi.org/10.1186/s13613-015-0103-7

Published Print: 2016

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Leroy, Olivier

Bailly, Sébastien

Gangneux, Jean-Pierre

Mira, Jean-Paul

Devos, Patrick

Dupont, Hervé

Montravers, Philippe

Perrigault, Pierre-François

Constantin, Jean-Michel

Guillemot, Didier

Azoulay, Elie

Lortholary, Olivier

Bensoussan, Caroline

Timsit, Jean-François
License Information

Text and Data Mining valid from 2016-01-01

Text and Data Mining valid from 2016-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-015-0103-7

Content Type: article

Copyright: Copyright © 2016 Leroy et al. 2016. Published by Elsevier Masson SAS